Michael Chuong, M.D.

Michael Chuong, M.D., is a board-certified radiation oncologist at Baptist Health Miami Cancer Institute. He is the Director of Proton Therapy and Photon Therapy, Director of MR-Guided Radiation Therapy, and Director of Clinical Research within the Radiation Oncology Department at Baptist Health Miami Cancer Institute. He is also the lead physician for the gastrointestinal radiation oncology service.

Dr. Chuong serves as the vice chair of education and clinical research and is a professor of radiation oncology at the Florida International University Herbert Wertheim College of Medicine. Dr. Chuong received his medical degree from the University of South Florida College of Medicine in Tampa, Florida and completed his residency training in radiation oncology at the H. Lee Moffitt Cancer Center and Research Institute.

He previously served as assistant professor of radiation oncology at the University of Maryland School of Medicine and Maryland Proton Treatment Center in Baltimore where he was active in translational and clinical research. Dr. Chuong is widely published in peer-reviewed medical journals and has received numerous awards, including the American Society of Clinical Medicine Conquer Cancer Foundation Merit Award and the Moffitt Cancer Center Research Symposium Clinical Research Symposium Clinical Research Award. He has successfully received grant funding to support his research and is the principal investigator for several national and international clinical trials that are exploring advanced radiation therapy strategies and unique combinations of radiation therapy with novel therapeutic agents for gastrointestinal cancers.

Dr. Chuong has leadership positions within several national and international organiszations including NRG Oncology, the Proton Collaborative Group, and the Particle Therapy Co-operative Group. His professional affiliations include the American Society of Clinical Oncology, the American Society of Therapeutic Radiation Oncology and the American College of Radiation Oncology.